copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Idiopathic Hypersomnia Symptoms and Treatment | XYWAV® IH XYWAV is the first and only FDA-approved medication to treat IH in adults XYWAV has been studied across multiple symptoms of IH, such as excessive daytime sleepiness, sleep inertia, cognitive impairment, and long sleep time
Xywav for idiopathic hypersomnia: Side effects, cost, and more Xywav is also approved to treat excessive daytime sleepiness and cataplexy (sudden muscle weakness) related to narcolepsy Side effects of Xywav when used to treat these narcolepsy-related
Xywav: Uses, Dosage, Side Effects, Warnings - Drugs. com Xywav is used for the treatment of cataplexy and excessive daytime sleepiness (EDS) in patients with narcolepsy, and idiopathic hypersomnia (IH) Includes Xywav side effects, interactions and indications
FDA-Approved Treatment for Idiopathic Hypersomnia | XYWAV HCP That’s why there’s XYWAV— the treatment taken each night to help manage multiple daily symptoms of IH, such as excessive daytime sleepiness (EDS), sleep inertia, cognitive impairment, and prolonged sleep time 6 IDENTIFY IH SYMPTOMS Actor portrayal
How Xywav Works, And Other Questions Answered - GoodRx Xywav was originally FDA-approved in 2002 to treat excessive daytime sleepiness (EDS) and cataplexy (sudden muscle weakness triggered by strong emotions) in people at least 7 years old who have narcolepsy It became FDA-approved for IH in adults in 2021 Xywav is unique because it’s the only medication that’s specifically FDA-approved for IH
Jazz Presents New Data on Xywavs Impact on Narcolepsy and IH | Sleep . . . Summary: At the 37th annual Psych Congress, Jazz Pharmaceuticals presented results from the phase 4 DUET trial on low-sodium Xywav, showing its effectiveness in treating excessive daytime sleepiness and improving sleep outcomes for adults with narcolepsy and idiopathic hypersomnia
Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing . . . Xywav is the only low-sodium oxybate approved by the U S Food and Drug Administration for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy and for adults with idiopathic hypersomnia The Xywav label recommends a nightly dose of 6-9 grams per night
Medications for Idiopathic Hypersomnia | PWN4PWN Xywav (calcium, magnesium, potassium, and sodium oxybates): This is the first and only FDA-approved treatment specifically for idiopathic hypersomnia in adults It is a lower-sodium oxybate formulation taken at night to treat symptoms such as excessive daytime sleepiness, sleep inertia, long sleep time, and cognitive impairment
XYWAV for Idiopathic Hypersomnia | XYWAV® IH Excessive daytime sleepiness Sleep inertia Severe grogginess or confusion when waking up regardless of how much sleep you get or how many alarms you set—feeling disoriented, irritable, or even clumsy when waking up and for hours afterwards